{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:06:20Z","timestamp":1793415980901,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01845-5","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:31:30Z","timestamp":1776745890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SIRT-1\/Nrf-2\/HO-1 antioxidant defense axis in adult attention-deficit\/hyperactivity disorder"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0224-8272","authenticated-orcid":false,"given":"Nilifer","family":"G\u00fcrb\u00fczer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-3692","authenticated-orcid":false,"given":"Alev","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-1534","authenticated-orcid":false,"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"1845_CR1","doi-asserted-by":"publisher","first-page":"113799","DOI":"10.1016\/j.biopha.2022.113799","volume":"155","author":"K Abu-Elfotuh","year":"2022","unstructured":"Abu-Elfotuh K, Abdel-Sattar SA, Abbas AN et al (2022) The protective effect of thymoquinone or\/and thymol against monosodium glutamate-induced attention-deficit\/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2\/HO-1, TLR4\/NF-\u03baB\/NLRP3\/caspase-1 and Wnt\/\u03b2-Catenin signaling pathways in rat model. Biomed Pharmacother 155:113799. https:\/\/doi.org\/10.1016\/j.biopha.2022.113799","journal-title":"Biomed Pharmacother"},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/antiox9020176","volume":"9","author":"L Alvarez-Arellano","year":"2020","unstructured":"Alvarez-Arellano L, Gonz\u00e1lez-Garc\u00eda N, Salazar-Garc\u00eda M, Corona JC (2020) Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit\/Hyperactivity Disorder. Antioxidants 9:176. https:\/\/doi.org\/10.3390\/antiox9020176","journal-title":"Antioxidants"},{"key":"1845_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0224-3","volume":"8","author":"V Carafa","year":"2016","unstructured":"Carafa V, Rotili D, Forgione M et al (2016) Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics 8:61. https:\/\/doi.org\/10.1186\/s13148-016-0224-3","journal-title":"Clin Epigenetics"},{"key":"1845_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9111039","volume":"9","author":"JC Corona","year":"2020","unstructured":"Corona JC (2020) Role of Oxidative Stress and Neuroinflammation in Attention-Deficit\/Hyperactivity Disorder. Antioxidants 9:1039. https:\/\/doi.org\/10.3390\/antiox9111039","journal-title":"Antioxidants"},{"key":"1845_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1586\/ern.12.116","volume":"12","author":"S Cortese","year":"2012","unstructured":"Cortese S, Angriman M, Lecendreux M, Konofal E (2012) Iron and attention deficit\/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Rev Neurother 12:1227\u20131240. https:\/\/doi.org\/10.1586\/ern.12.116","journal-title":"Expert Rev Neurother"},{"key":"1845_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/15622975.2011.570376","volume":"13","author":"S Cortese","year":"2012","unstructured":"Cortese S, Azoulay R, Castellanos FX et al (2012b) Brain iron levels in attention-deficit\/hyperactivity disorder: a pilot MRI study. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 13:223\u2013231. https:\/\/doi.org\/10.3109\/15622975.2011.570376","journal-title":"World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry"},{"issue":"2","key":"1845_CR30","first-page":"77","volume":"10","author":"S Do\u011fan","year":"2009","unstructured":"Do\u011fan S, \u00d6nc\u00fc B, Sara\u00e7o\u011flu Varol G, K\u00fc\u00e7\u00fckg\u00f6nc\u00fc S (2009) Eri\u015fkin dikkat eksikli\u011fi hiperaktivite bozuklu\u011fu kendi bildirim \u00f6l\u00e7e\u011fi (ASRS-v1.1): T\u00fcrk\u00e7e formunun ge\u00e7erlilik ve g\u00fcvenilirli\u011fi. Anadolu Psikiyatri Dergisi 10(2):77\u201387","journal-title":"Anadolu Psikiyatri Dergisi"},{"key":"1845_CR7","first-page":"51","volume":"30","author":"M Elbir","year":"2019","unstructured":"Elbir M, Alp Topba\u015f \u00d6, Bayad S et al (2019) [Adaptation and Reliability of the Structured Clinical Interview for DSM-5-Disorders - Clinician Version (SCID-5\/CV) to the Turkish Language]. Turk Psikiyatri Derg Turk J Psychiatry 30:51\u201356","journal-title":"Turk Psikiyatri Derg Turk J Psychiatry"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191. https:\/\/doi.org\/10.3758\/bf03193146","journal-title":"Behav Res Methods"},{"key":"1845_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6782872","volume":"2020","author":"F Jiao","year":"2020","unstructured":"Jiao F, Gong Z (2020) The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev 2020:1\u201319. https:\/\/doi.org\/10.1155\/2020\/6782872","journal-title":"Oxid Med Cell Longev"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1087054713510354","volume":"19","author":"N Joseph","year":"2015","unstructured":"Joseph N, Zhang-James Y, Perl A, Faraone SV (2015) Oxidative stress and ADHD: a meta-analysis. J Atten Disord 19:915\u2013924. https:\/\/doi.org\/10.1177\/1087054713510354","journal-title":"J Atten Disord"},{"key":"1845_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/s0033291704002892","volume":"35","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Adler L, Ames M et al (2005) The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med 35:245\u2013256. https:\/\/doi.org\/10.1017\/s0033291704002892","journal-title":"Psychol Med"},{"key":"1845_CR31","volume-title":"DIVA 2.0. Diagnostic Interview Voor ADHD in Adults bij volwassenen [DIVA 20 Diagnostic Interview ADHD in Adults]","author":"JJS Kooij","year":"2010","unstructured":"Kooij JJS, Francken MH (2010) DIVA 2.0. Diagnostic Interview Voor ADHD in Adults bij volwassenen [DIVA 20 Diagnostic Interview ADHD in Adults]. DIVA Foundation"},{"key":"1845_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000489635","volume":"25","author":"DT Leffa","year":"2018","unstructured":"Leffa DT, Torres ILS, Rohde LA (2018) A review on the role of inflammation in attention-deficit\/hyperactivity disorder. Neuroimmunomodulation 25:328\u2013333. https:\/\/doi.org\/10.1159\/000489635","journal-title":"Neuroimmunomodulation"},{"key":"1845_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153297","volume":"479","author":"Z Liu","year":"2022","unstructured":"Liu Z, Shi B, Wang Y et al (2022) Curcumin alleviates aristolochic acid nephropathy based on SIRT1\/Nrf2\/HO-1 signaling pathway. Toxicology 479:153297. https:\/\/doi.org\/10.1016\/j.tox.2022.153297","journal-title":"Toxicology"},{"key":"1845_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12402-015-0170-5","volume":"7","author":"AL Lopresti","year":"2015","unstructured":"Lopresti AL (2015) Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies. ADHD Atten Deficit Hyperact Disord 7:237\u2013247. https:\/\/doi.org\/10.1007\/s12402-015-0170-5","journal-title":"ADHD Atten Deficit Hyperact Disord"},{"key":"1845_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179284","volume":"25","author":"HI Mokhtar","year":"2024","unstructured":"Mokhtar HI, Abd El-Fadeal NM, El-Sayed RM et al (2024) Computational analysis and experimental data exploring the role of hesperetin in ameliorating ADHD and SIRT1\/Nrf2\/Keap1\/OH-1 signaling. Int J Mol Sci 25:9284. https:\/\/doi.org\/10.3390\/ijms25179284","journal-title":"Int J Mol Sci"},{"key":"1845_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/pcn.12931","volume":"73","author":"FL Os\u00f3rio","year":"2019","unstructured":"Os\u00f3rio FL, Loureiro SR, Hallak JEC et al (2019) Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV). Psychiatry Clin Neurosci 73:754\u2013760. https:\/\/doi.org\/10.1111\/pcn.12931","journal-title":"Psychiatry Clin Neurosci"},{"key":"1845_CR17","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1177\/1087054716646451","volume":"23","author":"JA Ramos-Quiroga","year":"2019","unstructured":"Ramos-Quiroga JA, Nasillo V, Richarte V et al (2019) Criteria and Concurrent Validity of DIVA 2.0: A Semi-Structured Diagnostic Interview for Adult ADHD. J Atten Disord 23:1126\u20131135. https:\/\/doi.org\/10.1177\/1087054716646451","journal-title":"J Atten Disord"},{"key":"1845_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115545","volume":"485","author":"R Rana","year":"2025","unstructured":"Rana R, Mukherjee R, Mehan S et al (2025) Molecular mechanisms of neuroprotection: the interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health. Behav Brain Res 485:115545. https:\/\/doi.org\/10.1016\/j.bbr.2025.115545","journal-title":"Behav Brain Res"},{"key":"1845_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph15081012","volume":"15","author":"HA Salem","year":"2022","unstructured":"Salem HA, Elsherbiny N, Alzahrani S et al (2022) Neuroprotective effect of morin hydrate against attention-deficit\/hyperactivity disorder (ADHD) induced by MSG and\/or protein malnutrition in rat pups: effect on oxidative\/monoamines\/inflammatory balance and apoptosis. Pharmaceuticals 15:1012. https:\/\/doi.org\/10.3390\/ph15081012","journal-title":"Pharmaceuticals"},{"key":"1845_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jaac.2012.08.015","volume":"51","author":"C Scassellati","year":"2012","unstructured":"Scassellati C, Bonvicini C, Faraone SV, Gennarelli M (2012) Biomarkers and attention-deficit\/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 51:1003-1019e.e20. https:\/\/doi.org\/10.1016\/j.jaac.2012.08.015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1845_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.115280","volume":"476","author":"P Sethi","year":"2025","unstructured":"Sethi P, Mehan S, Khan Z et al (2025) The SIRT-1\/Nrf2\/HO-1 axis: guardians of neuronal health in neurological disorders. Behav Brain Res 476:115280. https:\/\/doi.org\/10.1016\/j.bbr.2024.115280","journal-title":"Behav Brain Res"},{"key":"1845_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","volume":"43","author":"V Singh","year":"2020","unstructured":"Singh V, Ubaid S (2020) Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation 43:1589\u20131598. https:\/\/doi.org\/10.1007\/s10753-020-01242-9","journal-title":"Inflammation"},{"key":"1845_CR23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1080\/20473869.2023.2185959","volume":"70","author":"F Subasi Turgut","year":"2024","unstructured":"Subasi Turgut F, Karadag M, Taysi S et al (2024) NRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study. Int J Dev Disabil 70:1441\u20131451. https:\/\/doi.org\/10.1080\/20473869.2023.2185959","journal-title":"Int J Dev Disabil"},{"key":"1845_CR24","unstructured":"Tatar DZB, Yargi\u00e7 D\u0130, Oflaz DS, B\u00fcy\u00fckg\u00f6k PD Eri\u015fkin Dikkat Eksikli\u011fi Hiperaktivite Bozuklu\u011funda Duygu Tan\u0131man\u0131n Dikkat ve D\u00fcrt\u00fcsellik Belirtileri ile \u0130li\u015fkisi \u2022"},{"key":"1845_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.25048\/tudod.808316","volume":"5","author":"\u0130 Ulu","year":"2021","unstructured":"Ulu \u0130, \u00c7akmak Gen\u00e7 G, Karaka\u015f \u00c7eli\u0307K S (2021) Sirtuin 1 ve Sirtuin 2\u2019nin Tip 2 Diyabet ile \u0130li\u015fkisi. Turk J Diabetes Obes 5:81\u201388. https:\/\/doi.org\/10.25048\/tudod.808316","journal-title":"Turk J Diabetes Obes"},{"key":"1845_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00702-020-02231-w","volume":"127","author":"A Uzun Cicek","year":"2020","unstructured":"Uzun Cicek A, Mercan Isik C, Bakir S et al (2020) Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit\/hyperactivity disorder (ADHD). J Neural Transm 127:1409\u20131418. https:\/\/doi.org\/10.1007\/s00702-020-02231-w","journal-title":"J Neural Transm"},{"key":"1845_CR27","doi-asserted-by":"crossref","unstructured":"Visternicu M, Rarinca V, Burlui V et al (2024) Investigating the Impact of Nutrition and Oxidative Stress. on Attention Deficit Hyperactivity Disorder","DOI":"10.20944\/preprints202407.1990.v1"},{"key":"1845_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cbi.2019.05.003","volume":"306","author":"L-M Yu","year":"2019","unstructured":"Yu L-M, Dong X, Xue X-D et al (2019) Protection of the myocardium against ischemia\/reperfusion injury by punicalagin through an SIRT1-NRF-2-HO-1-dependent mechanism. Chem Biol Interact 306:152\u2013162. https:\/\/doi.org\/10.1016\/j.cbi.2019.05.003","journal-title":"Chem Biol Interact"},{"key":"1845_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.lfs.2018.01.027","volume":"197","author":"M Zhu","year":"2018","unstructured":"Zhu M, Tian Y, Zhang H et al (2018) Methylphenidate ameliorates hypoxia-induced mitochondrial damage in human neuroblastoma SH-SY5Y cells through inhibition of oxidative stress. Life Sci 197:40\u201345. https:\/\/doi.org\/10.1016\/j.lfs.2018.01.027","journal-title":"Life Sci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01845-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:27:25Z","timestamp":1781648845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01845-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01845-5","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Scientific Research Ethics Committee of Erzurum Medical Faculty, University of Health Sciences (Erzurum, T\u00fcrkiye) with decision number BAEK 2024\/11\u2013210. The research was carried out in compliance with the Declaration of Helsinki ethical standards. All participants provided written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Artificial intelligence (AI) tools were used solely to improve the academic English language quality of this manuscript. The scientific content, interpretation of findings, and all intellectual contributions were made entirely by the authors. The authors have thoroughly reviewed and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI use declaration"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}